Syngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement ...

Syngene International, a global CRDMO, has extended its long-standing strategic collaboration with Bristol Myers Squibb ...

Warren Buffett made some substantial changes to the Berkshire Hathaway Inc. (NYSE: BRK.B) portfolio in the first quarters of ...

Syngene International has extended its long-term research collaboration with Bristol Myers Squibb until 2035. The expanded ...

Syngene International extends research collaboration with Bristol Myers Squibb through 2035, expanding drug development ...

Indian contract research, development, and manufacturing organization (CRDMO) Syngene International today announced the ...

The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform ...

BMS Foundation launches national programme to bolster mental health diversion initiatives: Lawrenceville, New Jersey Saturday, January 17, 2026, 12:00 Hrs [IST] The Bristol Myers ...

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...

BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...